Community Academic Profiles

Carlos Milla

Publication Details

  • Insulin glargine improves hemoglobin A1c in children and adolescents with poorly controlled type 1 diabetes.

    Jackson A, Ternand C, Brunzell C, Kleinschmidt T, Dew D, Milla C, Moran A. Pediatr Diabetes. 2003; 4 (2): 64-9

    The pediatric diabetes team at the University of Minnesota made a clinical decision to switch patients with type 1 diabetes with a hemoglobin A1c level greater than 8.0% to insulin glargine in an effort to improve glycemic control. Retrospective chart analysis was performed on 37 patients 6 months after the switch to insulin glargine therapy.

    PubMedID: 14655261

Stanford Medicine Resources:

Footer Links: